Brief: Promore Pharma Reached The Targeted Number Of Patients Completing Treatment

PMD Device Solutions AB

24/03/2020 12:33

March 24 (Reuters) - Promore Pharma AB  PROMO.ST :
    * PROMORE PHARMA REACHED THE TARGETED NUMBER OF PATIENTS COMPLETING TREATMENT IN THE HEAL
LL-37
PHASE IIB CLINICAL TRIAL
    * PROMORE PHARMA AB - ASSESSES THAT RESULTS FROM STUDY CAN BE PRESENTED IN Q4 2020 IN
ACCORDANCE
WITH EARLIER COMMUNICATIONS.
    * PROMORE PHARMA AB - REACHED ITS TARGET OF TREATING 120 PATIENTS WITH LL-37 FOR THREE
MONTHS.

Source text for Eikon:  ID:nWkr55bxKr 
Further company coverage:  PROMO.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))